COPPER INTELLIGENCE TO FORM AN EARLY-STAGE EXPLORATION JOINT VENTURE WITH COTEC TO TARGET PROCESSING HISTORICAL COPPER TAILINGS OPPORTUNITIES IN THE DEMOCRATIC REPUBLIC OF CONGO
Copper tailings in the DRC are a defining feature of the DRC's long mining history, particularly in the Central African Copperbelt, one of the world's richest copper and cobalt provinces. Large volumes of tailings have been generated by the state-owned company Gécamines during industrial mining since the 1950s.
Once formed, the Joint Venture will establish a framework for pursuing copper-tailings opportunities in the DRC's historical copper districts. Opportunities identified will be subject to detailed legal and technical due diligence and binding agreements on an asset-by-asset basis with approval by the independent members of the CoTec Board of Directors in this matter, prior to resources being committed to development.
CoTec technologies will be used to further enhance the economic potential of these historical tailings sites and redundant copper deposits. The Joint Venture will target funding from the U.S. International Development Finance Corporation once sufficient scale is achieved. Copper Intelligence is the first stand-alone DRC company to be publicly traded in
The term sheet is non-binding and the specific structure, terms and conditions of the Joint Venture will be reflected in mutually acceptable definitive agreements.
About Copper Intelligence
Copper Intelligence is a resource development company focused on copper exploration and project advancement in the
Click here to continue reading.
For further information, please contact:
Rubenstein Public Relations - [email protected]
SOURCE Copper Intelligence Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The Football Stars Missing This Summer's Cup Receive an Invitation from Ecuador
- Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
- New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple my
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share